Characterization of 5α-reductase gene expression in stroma and epithelium of human prostate

Journal of Steroid Biochemistry and Molecular Biology

Volumn 59, Issue 5-6, 1996, Pages 397-404

  Bruchovsky, Nicholas ^a   Sadar, Marianne D ^a   Akakura, Koichiro ^b   Goldenberg, S Larry ^a   Matsuoka, Kei ^c   Rennie, Paul S ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b Chiba University   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

17BETA (N,N DIETHYLCARBAMOYL) 4 METHYL 4 AZA 5ALPHA ANDROSTAN 3 ONE; ISOENZYME; MESSENGER RNA; STEROID 5ALPHA REDUCTASE; 17 N,N DIETHYLCARBAMOYL 4 METHYL 4 AZAANDROSTANE 3 ONE; 17-N,N-DIETHYLCARBAMOYL-4-METHYL-4-AZAANDROSTANE-3-ONE; ANDROSTANOLONE; ANTIANDROGEN; AZASTEROID; CHOLESTENONE 5ALPHA REDUCTASE; DRUG DERIVATIVE; OXIDOREDUCTASE;

ADULT; AGED; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PROSTATE EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; BIOSYNTHESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM; GENE EXPRESSION REGULATION; GENETICS; HYPERPLASIA; KINETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE TUMOR; STROMA CELL;

AGED; ANDROGEN ANTAGONISTS; AZASTEROIDS; BLOTTING, NORTHERN; CHOLESTENONE 5 ALPHA-REDUCTASE; DIHYDROTESTOSTERONE; EPITHELIUM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERPLASIA; ISOENZYMES; KINETICS; MALE; MIDDLE AGED; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS; RNA, MESSENGER; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 0030300128     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00125-2     Document Type: Article

References (39)

1. 1. Siiteri P. K. and Wilson J. D.: Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man. J. Clin. Invest. 49 (1970) 1737-1745.
2. 2. Wilson J. D.: The pathogenesis of benign prostatic hyperplasia. Am. J. Med. 68 (1980) 745-756.
3. 3. Sansone-Bazzano G. and Reisner R. M.: Differential rates of conversion of testosterone to 5α-dihydrotestosterone in acne and normal human skin - a possible pathogenic factor in acne. J. Invest. Derm. 56 (1971) 366-372.
4. 4. Jenkins J. S. and Ash S.: The metabolism of testosterone by human skin in disorders of hair growth. J. Endocr. 59 (1973) 345-351.
5. 5. Serafino P., Ablan F. and Lobo R.: 5α-Reductase activity in the genital skin of hirsute women. J. Clin. Endocr. Metab. 60 (1985) 349-352.
6. 6. Bingham K. D. and Shaw D. A.: The metabolism of testosterone by human male skin. J. Endocr. 57 (1973) 111-121.
7. 7. Bruchovsky N., Rennie P. S., Batzold F. H., Goldenberg S. L., Fletcher T. and McLoughlin M. G.: Kinetic parameters of 5α-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J. Clin. Endocr. Metab. 67 (1988) 806-816.
8. 8. Geller J., Albert J., de la Vega D., Lopez D. and Stoeltzing W.: Dihydrotesteosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency. Cancer Res. 38 (1978) 4349-4351.
9. 9. Habib F. K., Busuttil A. and Chisholm G. D.: 5α-Reductase: a possible biological marker in the treatment of prostate cancer. The Prostate 3 (1982) 309.
10. 10. Normington K. and Russell D. W.: Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes. J. Biol. Chem. 267 (1992) 19548-19554.
11. 11. Barnea A., Hajibeigi A., Trant J. M. and Mason J. I.: Expression of steroid metabolizing enzymes by aggregating fetal brain cells in culture: a model for developmental regulation of the progesterone 5α-reductase pathway. Endocrinology 127 (1990) 500-502.
12. 12. Celotti F., Melcangi R. C. and Martini L.: The 5α-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocr. 13 (1992) 163-215.
13. 13. Verhoeven G., Lamberigts G. and De Moor P.: Nucleus-associated steroid 5α-reductase activity and androgen responsiveness. A study in various organs and brain regions of rats. J. Steroid Biochem. 5 (1974) 93-100.
14. 14. Berman B. M. and Russell D. W.: Cell-type specific expression of rat steroid 5α-reductase isoenyzmes. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 9359-9363.
15. 15. Thigpen A. E., Silver R. I., Guileyardo J. M., Casey M. L., McConnell J. D. and Russell D. W.: Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J. Clin. Invest. 92 (1993) 903-910.
16. 16. George F. W., Russell D. W. and Wilson J. D.: Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase. Proc. Natn. Acad. Sci. U.S.A. 88 (1991) 8044-8047.
17. 17. Andersson S., Berman D. M., Jenkins E. P. and Russell D. W.: Deletion of steroid 5α-reductase II gene in male pseudohermaphroditism. Nature 354 (1991) 159-161.
18. 18. Andersson S., Bishop R. W. and Russell D. W.: Expression, cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J. Biol. Chem. 264 (1989) 16249-16255.
19. 19. Andersson S. and Russell D. W.: Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. Natn. Acad. Sci. U.S.A. 87 (1990) 3640-3644.
20. 20. Moore R. J. and Wilson J. D.: Steroid 5α-reductase in cultured human fibroblasts: biochemical and genetic evidence for two distinct enzyme activities. J. Biol. Chem. 251 (1976) 5895-5900.
21. 21. Thigpen A. E., Cala K. M. and Russell D. W.: Characterization of Chinese Hamster Ovary cell lines expressing human steroid 5α-reductase isozymes. J. Biol. Chem. 268 (1993) 17404-17412.
22. 22. Luu-The V., Sugimoto Y., Puy L., Labrie Y., Solache I. L., Singh M. and Labrie F.: Characterization, expression, and immunohistochemical localization of 5α-reductase in human skin. J. Clin. Invest. Derm. 102 (1994) 221-226.
23. 23. Silver R. I., Wiley E. L., Thigpen A. E., Guileyardo J. M., McConnell J. D. and Russell D. W.: Cell type specific expression of steroid 5α-reductase 2. J. Urol. 152 (1994) 438-442.
24. 24. Bonnet P., Reiter E., Bruyninx M., Sente B., Dombrowicz D., de Leval J., Closset J. and Heenen G.: Benign prostatic hyperplasia and normal prostate ageing: differences in types I and II 5α-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J. Clin. Endocr. Metab. 77 (1993) 1203-1208.
25. 25. Bruchovsky N., McLoughlin M., Rennie P. S. and To M., Partial characterization of stromal and epithelial forms of 5α-reductase in human prostate. In The Prostate Cell: Structure and Function, Part A, eds G. P. Murphy, A. A. Sandberg and J. P. Karr. Alan R. Liss Inc., New York, 1981, pp. 161-175.
26. 26. Chomczynski P. and Sacchi N.: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162 (1987) 156-159.
27. 27. Aviv H. and Leder P.: Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natn. Acad. Sci. U.S.A. 69 (1972) 1408-1413.
28. 28. Beverley S. M., Enzymatic amplification of RNA by PCR. In Current Protocols in Molecular Biology, eds F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith and K. Struh. Greene Publishing Associates and Wiley-Interscience, New York, 1989, p. 15.4.
29. 29. Kaighn M. E., Shankar N. Y., Ohnuki Y., Lechner J. F. and Jones L. W.: Establishment and characterization of human prostatic carcinoma cell line (PC-3). Invest. Urol. 17 (1979) 16 23.
30. 30. Stone K. R., Mickey D. D., Wunderli H., Mickey G. H. and Paulson D. F.: Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 21 (1978) 274-281.
31. 31. Horoszewicz J. S., Leong S. S., Kawinski E., Karr J. P., Rosenthal H., Ming Chu T., Mirand E. A. and Murphy G. P.: LNCaP model of human prostatic carcinoma. Cancer Res. 43 (1983) 1809-1818.
32. 32. Segel I. H., Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady State Enzyme Systems. Wiley and Sons, New York, 1975, pp. 46, 109, 134 and 214.
33. 33. Jenkins E. P., Andersson S., Imperato-McGinely J., Wilson J. D. and Russell D. W.: Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J. Clin. Invest. 89 (1992) 293-300.
34. 34. Délos S., Carsol J.-L., Ghazarossian E., Raynaud J.-P. and Martin P.-M.: Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J. Steroid Biochem. Molec. Biol. 55 (1995) 375-383.
35. 35. Eicheler W., Tuohimaa P., Vilja P., Adermann K., Forssmann W.-G. and Aumuller G.: Immunocytochemical localization of human 5α-reductase 2 with polyclonal antibodies in androgen target and non-target tissue. J. Histochem. Cytochem. 42 (1994) 667-675.
36. 36. Imperato-McGinley J., Gautier T., Zirinsy K., Hom T., Palomo O., Stein E., Vaughan E. D., Markisz J. A., Ramirez de Arellano E. and Kazam E.: Prostate visualization studies in males homozygous and heterozygous for 5α-reductase deficiency. J. Clin. Endocr. Metab. 75 (1992) 1022-1026.
37. 37. Rennie P. S., Bruchovsky N., McLoughlin M. G., Batzold F. H. and Dunstan-Adams E.: Kinetic analysis of 5α-reductase isoenzymes in benign prostatic hyperplasia (BPH). J. Steroid Biochem. 19 (1983) 169-173.
38. 38. Bruchovsky N. and Lieskovsky G.: Increased ratio of 5α-reductase:3α(β)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate. J Endocr. 80 (1979) 289-301.
39. 39. Wilkin R. P., Bruchovsky N., Shnitka T. K., Rennie P. S. and Comeau T. L.: Stromal 5α-reductase activity is elevated in benign prostatic hyperplasia. Acta Endocr. (Copenh) 94 (1980) 284-288.